Life Science

Rousselot Announces Partnership with Terasaki Institute for Biomedical Innovation

Wed, 12/01/2022 - 08:00
Irving, United States, 12th January 2022 / Sciad Newswire / Rousselot®, Darling Ingredients’ health brand and

New study confirms that purity and type of coating biomaterials used in 2D cell culturing are crucial for efficient stem cell proliferation

Thu, 09/12/2021 - 08:00
Irving, United States, 9th December 2021 / Sciad Newswire / Rousselot®, Darling Ingredients’ health
BioPure new Facility

BioPure receives the keys to its new custom built facility

Wed, 08/12/2021 - 08:00
BioPure’s new site will increase provision of vital fluid components to the biopharmaceutical industry The facility is five times the size of BioPure’s previous location

Antibiotic prescribing by GPs in England fell by 17% during the first 12 months of Covid without the usual winter increase

Thu, 11/11/2021 - 07:00
New research by Antibiotic Research UK hints at scale of over-prescribing in normal times

Chemineau develops new nasal spray production line with Flexicon filling system

Wed, 10/11/2021 - 07:30

Exclusive interview with Professor Sir John Bell announced as Life Science Integrates celebrates ten years of Pharma Integrates

Wed, 03/11/2021 - 09:30
London, UK, 3rd November 2021 / Sciad Newswire / Life Science Integrates (LSI) is delighted to announce the e

Antibiotic Research UK awards grants to fund research worth £200,000

Tue, 02/11/2021 - 07:30
York, UK, 2nd November 2021 / Sciad Newswire / Antibiotic Research UK (ANTRUK), the world’s first charity tac

Antibiotic Research UK’s annual lecture calls for global governments to transform funding of new antibiotic sales to prevent another health emergency

Thu, 28/10/2021 - 07:30
London, UK, 28th October 2021 / Sciad Newswire / The UK’s first charity focused on antibiotic resistance, Antibio

Pandemic innovations offer potential to drive advances in personalized medicine

Tue, 19/10/2021 - 14:00
New article discusses how COVID-19 biopharmaceutical innovations could drive advances in personalized medicine
Rousselot Biomedical Gelatin

Rousselot® Biomedical launches Quali-Pure™, a range of gelatins with controlled purity, supporting full compliance with new EU Medical Device Regulations and ISO 22442

Tue, 19/10/2021 - 11:00
Irving, USA, 19th October 2021 / Sciad Newswire / Rousselot®, the Health brand of Darling Ingredient

Pages